Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial.
To assess the clinical improvement (change in seizure frequency), safety and tolerability of patients with partial seizures following adjunctive therapy of pregabalin BID in addition to existing standard AEDs.
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Pregabalin In Partial Seizures (Preps) : An Open-Label, International, Multicenter Add-On Therapy Trial|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00141427
Show 57 Study Locations
|Study Director:||Pfizer CT.gov Call Center||Pfizer|